Since BE2 is a N-Myc amplified neuroblastoma that has moderate N-Myc expression, we wanted to assess whether BE2 tumors lacked an apoptotic response to DON at the 50mg/kg dosage because of insufficient N-Myc expression or because of insufficient exposure to DON. Here, MYCN is linked to neuroblastoma.